CheckMate 817: First-Line Nivolumab plus Ipilimumab in Patients with ECOG PS 2 and Other Special Populations with Advanced NSCLC

F. Barlesi; C. Audigier-Valette; E. Felip; T. Ciuleanu; K. Jao; E. Rijavec; L. Urban; J. Aucoin; C. Zannori; K. Vermaelen; O. A. Frontera; N. Ready; A. Curioni Fontecedro; H. Linardou; E. Poddubskaya; J. Fischer; I. Iordan; H. Groen; R. Pillai; S. Li; J. Fiore; H. Chang; A. Acevedo; L. Paz-Ares

doi:10.1016/j.jtho.2019.08.424

CheckMate 817: First-Line Nivolumab plus Ipilimumab in Patients with ECOG PS 2 and Other Special Populations with Advanced NSCLC

F. Barlesi, C. Audigier-Valette, E. Felip, T. Ciuleanu, K. Jao, E. Rijavec, L. Urban, J. Aucoin, C. Zannori, K. Vermaelen, O. A. Frontera, N. Ready, A. Curioni Fontecedro, H. Linardou, E. Poddubskaya, J. Fischer, I. Iordan, H. Groen, R. Pillai, S. LiJ. Fiore, H. Chang, A. Acevedo, L. Paz-Ares

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	S214-S215
Number of pages	2
Journal	Journal of Thoracic Oncology
Volume	14
Issue number	10
DOIs	https://doi.org/10.1016/j.jtho.2019.08.424
Publication status	Published - Oct-2019

Keywords

nivolumab
ipilimumab
NSCLC

Access to Document

10.1016/j.jtho.2019.08.424

Handle.net

Persistent link

Cite this

Barlesi, F., Audigier-Valette, C., Felip, E., Ciuleanu, T., Jao, K., Rijavec, E., Urban, L., Aucoin, J., Zannori, C., Vermaelen, K., Frontera, O. A., Ready, N., Fontecedro, A. C., Linardou, H., Poddubskaya, E., Fischer, J., Iordan, I., Groen, H., Pillai, R., ... Paz-Ares, L. (2019). CheckMate 817: First-Line Nivolumab plus Ipilimumab in Patients with ECOG PS 2 and Other Special Populations with Advanced NSCLC. Journal of Thoracic Oncology, 14(10), S214-S215. https://doi.org/10.1016/j.jtho.2019.08.424

@article{c0795f8586134697961a6e0931d2fcb0,

title = "CheckMate 817: First-Line Nivolumab plus Ipilimumab in Patients with ECOG PS 2 and Other Special Populations with Advanced NSCLC",

keywords = "nivolumab, ipilimumab, NSCLC",

author = "F. Barlesi and C. Audigier-Valette and E. Felip and T. Ciuleanu and K. Jao and E. Rijavec and L. Urban and J. Aucoin and C. Zannori and K. Vermaelen and Frontera, {O. A.} and N. Ready and Fontecedro, {A. Curioni} and H. Linardou and E. Poddubskaya and J. Fischer and I. Iordan and H. Groen and R. Pillai and S. Li and J. Fiore and H. Chang and A. Acevedo and L. Paz-Ares",

year = "2019",

month = oct,

doi = "10.1016/j.jtho.2019.08.424",

language = "English",

volume = "14",

pages = "S214--S215",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "ELSEVIER SCIENCE INC",

number = "10",

}

Barlesi, F, Audigier-Valette, C, Felip, E, Ciuleanu, T, Jao, K, Rijavec, E, Urban, L, Aucoin, J, Zannori, C, Vermaelen, K, Frontera, OA, Ready, N, Fontecedro, AC, Linardou, H, Poddubskaya, E, Fischer, J, Iordan, I, Groen, H, Pillai, R, Li, S, Fiore, J, Chang, H, Acevedo, A & Paz-Ares, L 2019, 'CheckMate 817: First-Line Nivolumab plus Ipilimumab in Patients with ECOG PS 2 and Other Special Populations with Advanced NSCLC', Journal of Thoracic Oncology, vol. 14, no. 10, pp. S214-S215. https://doi.org/10.1016/j.jtho.2019.08.424

TY - JOUR

T1 - CheckMate 817

T2 - First-Line Nivolumab plus Ipilimumab in Patients with ECOG PS 2 and Other Special Populations with Advanced NSCLC

AU - Barlesi, F.

AU - Audigier-Valette, C.

AU - Felip, E.

AU - Ciuleanu, T.

AU - Jao, K.

AU - Rijavec, E.

AU - Urban, L.

AU - Aucoin, J.

AU - Zannori, C.

AU - Vermaelen, K.

AU - Frontera, O. A.

AU - Ready, N.

AU - Fontecedro, A. Curioni

AU - Linardou, H.

AU - Poddubskaya, E.

AU - Fischer, J.

AU - Iordan, I.

AU - Groen, H.

AU - Pillai, R.

AU - Li, S.

AU - Fiore, J.

AU - Chang, H.

AU - Acevedo, A.

AU - Paz-Ares, L.

PY - 2019/10

Y1 - 2019/10

KW - nivolumab

KW - ipilimumab

KW - NSCLC

U2 - 10.1016/j.jtho.2019.08.424

DO - 10.1016/j.jtho.2019.08.424

M3 - Meeting Abstract

SN - 1556-0864

VL - 14

SP - S214-S215

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 10

ER -